Furthermore, pan-cancer analysis revealed that SLC25A4 expression was reduced in most tumors, and the cBioPortal database indicated that genetic alterations in SLC25A4 were strongly linked to OS patient prognosis. Here, SLC25A4 is linked to cancer.